Ana M. Wägner

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

Antoinette Moran, Brian N. Bundy, Dorothy Becker et al. · The Lancet · 2013 · 351 citations · Full text

Inflammation, Metabolic Syndrome, Type 1 +11

Therapy of severe diabetic ketoacidosis. Zero-mortality under very-low-dose insulin application.

Ana M. Wägner, Alexander Risse, Herbert Brill et al. · Diabetes Care · 1999 · 113 citations

Metabolic Syndrome, Basal Insulin Infusion, Diabetes Management +11

Hypothyroidism as a Cause of Rhabdomyolysis.

María José Barahona, Albert Mauri, Nuria Sucunza et al. · Endocrine Journal · 2002 · 82 citations · Full text

Creatine Kinase Concentrations, Physiology, Primary Hypothyroidism +7

Deciphering Tacrolimus-Induced Toxicity in Pancreatic β Cells

Javier Triñanes, Ana Elena Rodríguez‐Rodríguez, Yeray Brito‐Casillas et al. · American Journal of Transplantation · 2017 · 81 citations · Full text

Prevalence and Phenotypic Distribution of Dyslipidemia in Type 1 Diabetes Mellitus

Antonio Montes Pérez, Ana M. Wägner, Gemma Carreras et al. · Archives of Internal Medicine · 2000 · 79 citations